Minimizing the release of proinflammatory and toxic bacterial products within the host: A promising approach to improve outcome in life-threatening infections

FEMS Immunology and Medical Microbiology

Volumn 44, Issue 1, 2005, Pages 1-16

  Nau, Roland ^a   Eiffert, Helmut ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antibiotics; Bacterial DNA; Endotoxin; Lipoteichoic acids; Peptidoglycans; Toll like receptors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ENDOTOXIN; IMIPENEM; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LIPOTEICHOIC ACID; MACROLIDE; PENICILLIN G; PEPTIDE DERIVATIVE; PEPTIDOGLYCAN; POLYMYXIN; POLYMYXIN B; QUINOLONE DERIVATIVE; RIFAMPICIN; TEICHOIC ACID; TEICOPLANIN; UNINDEXED DRUG;

APOPTOSIS; BACTERIAL INFECTION; BACTERIAL MENINGITIS; ENDOTHELIUM CELL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOST; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NERVE CELL; NEUTROPHIL; NONHUMAN; PERITONITIS; PLAGUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 15044348891     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2005.01.001     Document Type: Short Survey

References (79)

1. D.M. Underhill Toll-like receptors: networking for success Eur. J. Immunol. 33 2003 1767 1775
2. H. Wagner The immunobiology of the TLR9 subfamily Trends Immunol. 25 2004 381 386
3. K.M. Kengatharan, S. De Kimpe, C. Robson, S.J. Foster, and C. Thiemermann Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure J. Exp. Med. 188 1998 305 315
4. K. Herxheimer, and K. Krause Ueber eine bei Syphilitischen vorkommende Quecksilberreaktion Dtsch. Med. Wochenschr. 28 1902 895 897
5. H. Eiffert, H. Lotter, K. Jarecki-Khan, and R. Thomssen Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi Med. Microbiol. Immunol. 180 1991 229 237
6. D.A. Hopkin Frapper fort ou frapper doucement: a Gram-negative dilemma Lancet 2 1978 1193 1194
7. B. Beutler Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity Curr. Opin. Microbiol. 3 2000 23 28
8. S. Bhakdi, T. Klonisch, P. Nuber, and W. Fischer Stimulation of monokine production by lipoteichoic acids Infect. Immun. 59 1991 4614 4620
9. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2 2001 675 680
10. S.J. De Kimpe, M. Kengatharan, C. Thiemermann, and J.R. Vane The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure Proc. Natl. Acad. Sci. USA 92 1995 10359 10363
11. L.H. Travassos, S.E. Girardin, D.J. Philpott, D. Blanot, M.A. Nahori, C. Werts, and I.G. Boneca Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition EMBO. Rep. 5 2004 1000 1006
12. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
13. S. Ebert, J. Gerber, S. Bader, F. Mühlhauser, K. Brechtel, T.J. Mitchell, and R. Nau Dose-dependent activation of microglial cells by toll-like receptor agonists alone and in combination J. Neuroimmunol. 159 2005 87 96
14. G.A. Bohach, D.J. Fast, R.D. Nelson, and P.M. Schlievert Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Crit. Rev. Microbiol. 17 1990 251 272
15. A. Spreer, H. Kerstan, T. Bottcher, J. Gerber, A. Siemer, G. Zysk, T.J. Mitchell, H. Eiffert, and R. Nau Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone Antimicrob. Agents Chemother. 47 2003 2649 2654
16. H. Schmidt, A. Tlustochowska, K. Stuertz, M. Djukic, J. Gerber, E. Schutz, U. Kuhnt, and R. Nau Organotypic hippocampal cultures. A model of brain tissue damage in Streptococcus pneumoniae meningitis J. Neuroimmunol. 113 2001 30 39
17. Y.S. Kim, and M.G. Tauber Neurotoxicity of glia activated by Gram-positive bacterial products depends on nitric oxide production Infect. Immun. 64 1996 3148 3153
18. J. Mertsola, W.A. Kennedy, D. Waagner, X. Saez-Llorens, K. Olsen, E.J. Hansen, and G.H. McCracken Jr. Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type B meningitis Am. J. Dis. Child 145 1991 1099 1103
19. R. Cockeran, A.J. Theron, C. Feldman, T.J. Mitchel, and R. Anderson Pneumolysin potentiates oxidative inactivation of α-1-proteinase inhibitor by activated human neutrophils Respir. Med. 98 2004 865 871
20. A.I. Iliev, A.K. Stringaris, R. Nau, and H. Neumann Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9) Faseb J. 18 2004 412 414
21. D. Freyer, R. Manz, A. Ziegenhorn, M. Weih, K. Angstwurm, W.D. Docke, A. Meisel, R.R. Schumann, G. Schonfelder, U. Dirnagl, and J.R. Weber Cerebral endothelial cells release TNF-α after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops J. Immunol. 163 1999 4308 4314
22. D.D. Bannerman, and S.E. Goldblum Direct effects of endotoxin on the endothelium: barrier function and injury Lab. Invest. 79 1999 1181 1199
23. R.A. Hirst, A. Rutman, K. Sikand, P.W. Andrew, T.J. Mitchell, and C. O'Callaghan Effect of pneumolysin on rat brain ciliary function: comparison of brain slices with cultured ependymal cells Pediatr. Res. 47 2000 381 384
24. A.K. Stringaris, J. Geisenhainer, F. Bergmann, C. Balshusemann, U. Lee, G. Zysk, T.J. Mitchell, B.U. Keller, U. Kuhnt, J. Gerber, A. Spreer, M. Bahr, U. Michel, and R. Nau Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase Neurobiol. Dis. 11 2002 355 368
25. J.M. Prins, S.J. van Deventer, E.J. Kuijper, and P. Speelman Clinical relevance of antibiotic-induced endotoxin release Antimicrob. Agents Chemother. 38 1994 1211 1218
26. J.L. Kadurugamuwa, and T.J. Beveridge Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release J. Antimicrob. Chemother. 40 1997 615 621
27. A.S. Dofferhoff, J.H. Nijland, H.G. de Vries-Hospers, P.O. Mulder, J. Weits, and V.J. Bom Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro and in vivo study Scand. J. Infect. Dis. 23 1991 745 754
28. J.J. Jackson, and H. Kropp β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime [see comments] J. Infect. Dis. 165 1992 1033 1041
29. J.M. Prins, M.A. van Agtmael, E.J. Kuijper, S.J. van Deventer, and P. Speelman Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime J. Infect. Dis. 172 1995 886 891
30. M.C. Mellado, R. Rodriguez-Contreras, A. Mariscal, J.D. Luna, M. Delgado Rodriguez, and R. Galvez-Vargas Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis Epidemiol. Infect. 106 1991 283 288
31. M.E. Evans, and M. Pollack Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli [see comments] J. Infect. Dis. 167 1993 1336 1343
32. D.J. Mason, E.G. Power, H. Talsania, I. Phillips, and V.A. Gant Antibacterial action of ciprofloxacin Antimicrob. Agents Chemother. 39 1995 2752 2758
33. D. Rifkind Prevention by polymyxin B of endotoxin lethality in mice J. Bacteriol. 93 1967 1463 1464
34. J.J. Corrigan Jr., and J.F. Kiernat Effect of polymyxin B sulfate on endotoxin activity in a Gram-negative septicemia model Pediatr. Res. 13 1979 48 51
35. J.N. Walterspiel, S.L. Kaplan, E.O. Mason Jr., and J.W. Walterspiel Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment [published erratum appears in Pediatr Res 1987 Dec;22(6):654] Pediatr. Res. 20 1986 237 241
36. J.L. Shenep, R.P. Barton, and K.A. Mogan Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis J. Infect. Dis. 151 1985 1012 1018
37. A. Foca, G. Matera, M.C. Berlinghieri, M.C. Liberto, and G.B. De Sarro Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide [see comments] J. Antimicrob. Chemother. 29 1992 443 446
38. N.M. Boe, E.P. Dellinger, and B.H. Minshew Effect of clindamycin on growth and haemolysin production by Escherichia coli J. Antimicrob. Chemother. 12 Suppl C 1983 105 116
39. K. Kishi, K. Hirai, K. Hiramatsu, T. Yamasaki, and M. Nasu Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor α and interleukin-1 β Antimicrob. Agents Chemother. 43 1999 616 622
40. Y. Imamura, K. Yanagihara, Y. Mizuta, M. Seki, H. Ohno, Y. Higashiyama, Y. Miyazaki, K. Tsukamoto, Y. Hirakata, K. Tomono, J. Kadota, and S. Kohno Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells Antimicrob. Agents Chemother. 48 2004 3457 3461
41. D.J. Wozniak, and R. Keyser Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa Chest 125 2004 62S 69S quiz 69S
42. K.W. Tsang, P. Ng, P.L. Ho, S. Chan, G. Tipoe, R. Leung, J. Sun, J.C. Ho, M.S. Ip, and W.K. Lam Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Eur. Respir. J. 21 2003 401 406
43. K. Stuertz, H. Schmidt, H. Eiffert, P. Schwartz, M. Mader, and R. Nau Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to β-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin Antimicrob. Agents Chemother. 42 1998 277 281
44. J. Gerber, K. Pohl, V. Sander, S. Bunkowski, and R. Nau Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone Antimicrob. Agents Chemother. 47 2003 1313 1317
45. J. Gerber, H. Eiffert, A. Wellmer, H. Fleischer, and R. Nau Reduced relese of DNA from streptococcus pneumoniae after treatment with rifampin in comparison to ceftriaxone and spontaneous growth Eur. J. Clin. Microbiol. Infect. Dis. 20 2001 490 493
46. P. van Langevelde, J.T. van Dissel, E. Ravensbergen, B.J. Appelmelk, I.A. Schrijver, and P.H. Groeneveld Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities Antimicrob. Agents Chemother. 42 1998 3073 3078
47. P. van Langevelde, K.M. Kwappenberg, P.H. Groeneveld, H. Mattie, and J.T. van Dissel Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS Antimicrob. Agents Chemother. 42 1998 739 743
48. P.M. Schlievert, and J.A. Kelly Clindamycin-induced suppression of toxic-shock syndrome - associated exotoxin production J. Infect. Dis. 149 1984 471
49. N. Dickgiesser, and U. Wallach Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations Infection 15 1987 351 353
50. S. Sriskandan, A. McKee, L. Hall, and J. Cohen Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes J. Antimicrob. Chemother. 40 1997 275 277
51. A.M. Shibl, and I.A. Al-Sowaygh Differential inhibition of bacterial growth and hemolysin production by lincosamide antibiotics J. Bacteriol. 137 1979 1022 1023
52. D.M. Simon, G. Koenig, and G.M. Trenholme Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli J. Infect. Dis. 164 1991 800 802
53. M. Arditi, and J. Zhou Differential antibiotic-induced endotoxin release and interleukin-6 production by human umbilical vein endothelial cells (HUVECs): amplification of the response by coincubation of HUVECs and blood cells J. Infect. Dis. 175 1997 1255 1258
54. E. Mattsson, H. Van Dijk, J. Verhoef, R. Norrby, and J. Rollof Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor α from human monocytes Infect. Immun. 64 1996 4351 4355
55. T. Bottcher, J. Gerber, A. Wellmer, A.V. Smirnov, F. Fakhrjanali, E. Mix, J. Pilz, U.K. Zettl, and R. Nau Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis J. Infect. Dis. 181 2000 2095 2098
56. M.M. Mustafa, J. Mertsola, O. Ramilo, X. Saez-Llorens, R.C. Risser, and G.H. McCracken Jr. Increased endotoxin and interleukin-1 β concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy J. Infect. Dis. 160 1989 891 895
57. M. Burroughs, E. Rozdzinski, S. Geelen, and E. Tuomanen A structure-activity relationship for induction of meningeal inflammation by muramyl peptides J. Clin. Invest. 92 1993 297 302
58. M.G. Tauber, A.M. Shibl, C.J. Hackbarth, J.W. Larrick, and M.A. Sande Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits J. Infect. Dis. 156 1987 456 462
59. M.M. Paris, S.M. Hickey, M.I. Uscher, S. Shelton, K.D. Olsen, and G.H. McCracken Jr. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob. Agents Chemother. 38 1994 1320 1324
60. I.R. Friedland, H. Jafari, S. Ehrett, S. Rinderknecht, M. Paris, M. Coulthard, H. Saxen, K. Olsen, and G.H. McCracken Jr. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis J. Infect. Dis. 168 1993 657 662 (published erratum appears in J Infect Dis 1993 November, 168(5), p. 1342)
61. R. Nau, G. Zysk, H. Schmidt, F.R. Fischer, A.K. Stringaris, K. Stuertz, and W. Bruck Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis J. Antimicrob. Chemother. 39 1997 781 788
62. T. Bottcher, H. Ren, M. Goiny, J. Gerber, J. Lykkesfeldt, U. Kuhnt, M. Lotz, S. Bunkowski, C. Werner, I. Schau, A. Spreer, S. Christen, and R. Nau Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone J. Neurochem. 91 2004 1450 1460
63. R. Nau, A. Wellmer, A. Soto, K. Koch, O. Schneider, H. Schmidt, J. Gerber, U. Michel, and W. Bruck Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis J. Infect. Dis. 179 1999 1557 1560
64. S.E. Bucklin, and D.C. Morrison Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis J. Infect. Dis. 172 1995 1519 1527
65. S.M. Opal, D.L. Horn, J.E. Palardy, N. Parejo, J. Jhung, A. Bhattacharjee, and L.D. Young The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis J. Endotoxin Res. 3 1996 245 252
66. T. Kirikae, M. Nakano, and D.C. Morrison Antibiotic-induced endotoxin release from bacteria and its clinical significance Microbiol. Immunol. 41 1997 285 294.
67. I. Azeh, J. Gerber, A. Wellmer, M. Wellhausen, B. Koenig, H. Eiffert, and R. Nau Protein synthesis inhibiting clindamycin improves outcome in a mouse model of Staphylococcus aureus sepsis compared with the cell wall active ceftriaxone Crit. Care Med. 30 2002 1560 1564
68. T. Yokochi, K. Narita, A. Morikawa, K. Takahashi, Y. Kato, T. Sugiyama, N. Koide, M. Kawai, M. Fukada, and T. Yoshida Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin Antimicrob. Agents Chemother. 44 2000 205 206
69. W.R. Byrne, S.L. Welkos, M.L. Pitt, K.J. Davis, R.P. Brueckner, J.W. Ezzell, G.O. Nelson, J.R. Vaccaro, L.C. Battersby, and A.M. Friedlander Antibiotic treatment of experimental pneumonic plague in mice Antimicrob. Agents Chemother. 42 1998 675 681
70. A.J. Simpson, S.M. Opal, B.J. Angus, J.M. Prins, J.E. Palardy, N.A. Parejo, W. Chaowagul, and N.J. White Differential antibiotic-induced endotoxin release in severe melioidosis J. Infect. Dis. 181 2000 1014 1019
71. J. Zimbelman, A. Palmer, and J. Todd Improved outcome of clindamycin compared with β-lactam antibiotic treatment for invasive Streptococcus pyogenes infection Pediatr. Infect. Dis. J. 18 1999 1096 1100
72. O. Schneider, U. Michel, G. Zysk, O. Dubuis, and R. Nau Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations Neurology 53 1999 1584 1587
73. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, S. Zhu, J. Bian, L. Guo, L.A. Farrell, S.M. Hersch, W. Hobbs, J.P. Vonsattel, J.H. Cha, and R.M. Friedlander Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat. Med. 6 2000 797 801
74. J. Yrjanheikki, T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc. Natl. Acad. Sci. USA 96 1999 13496 13500
75. E. Kostadima, S. Tsiodras, E.I. Alexopoulos, A.G. Kaditis, I. Mavrou, N. Georgatou, and A. Papamichalopoulos Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma Eur. Respir. J. 23 2004 714 717
76. A. Dalhoff, and I. Shalit Immunomodulatory effects of quinolones Lancet Infect. Dis. 3 2003 359 371
77. J.M. Hamilton-Miller Immunopharmacology of antibiotics: direct and indirect immunomodulation of defence mechanisms J. Chemother. 13 2001 107 111
78. J.D. Bau mgartner, and T. Calandra Treatment of sepsis: past and future avenues Drugs 57 1999 127 132
79. R. Nau, and H. Eiffert Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis Clin. Microbiol. Rev. 15 2002 95 110